These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3330116

  • 21. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM, Malamet R, Wise RA.
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB, Guseva NG, Mach ES.
    Ter Arkh; 1987 Aug; 59(4):89-92. PubMed ID: 3296288
    [Abstract] [Full Text] [Related]

  • 23. [Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex].
    Varela-Aguilar JM, Sánchez-Román J, Talegón Meléndez A, Castillo Palma MJ.
    Rev Clin Esp; 1997 Feb; 197(2):77-83. PubMed ID: 9213861
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T, Kelbaek H, Hartling OJ, Nielsen SL.
    Am Heart J; 1986 Apr; 111(4):742-5. PubMed ID: 3513504
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon.
    Challenor VF, Waller DG, Hayward RA, Griffin MJ, Roath OS.
    Angiology; 1989 Feb; 40(2):122-8. PubMed ID: 2644877
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP, Weinberger MH, Gavras H, Gavras I, Brown TS, Deterding J, Klotman PE.
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [Abstract] [Full Text] [Related]

  • 33. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM, Korn JH, Csuka ME, Medsger TA, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Merkel PA, Gruber B, Kaufman L, Varga J, Bell P, Kern J, Marrott P, White B, Simms RW, Phillips AC, Seibold JR.
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [Abstract] [Full Text] [Related]

  • 34. [Usefulness of photoplethysmography and indexes of digital pressure in Raynaud phenomenon].
    Martínez S, Lozano P, Pallarés L, Juliá J, Artigues I, Plaza A, Rimbau EM, Corominas C, Gómez FT.
    Med Clin (Barc); 1999 Sep 25; 113(9):327-30. PubMed ID: 10562927
    [Abstract] [Full Text] [Related]

  • 35. Assessment of pinacidil in patients with primary Raynaud's phenomenon.
    Dompeling EC, Smit AJ.
    Vasa Suppl; 1992 Sep 25; 34():34-7. PubMed ID: 1529416
    [Abstract] [Full Text] [Related]

  • 36. Quantitative study of the effects of Ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial.
    van de Wal HJ, Wijn PF, van Lier HJ, Skotnicki SH.
    Microcirc Endothelium Lymphatics; 1985 Sep 25; 2(6):657-85. PubMed ID: 2942753
    [Abstract] [Full Text] [Related]

  • 37. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
    Riccio A, Del Puente A, Farinaro C, Scarpa R, Oriente P, Rocco P, Gioia M.
    Clin Ther; 1987 Sep 25; 9(2):232-7. PubMed ID: 3568066
    [Abstract] [Full Text] [Related]

  • 38. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
    Smith CD, McKendry RJ.
    Lancet; 1982 Dec 11; 2(8311):1299-301. PubMed ID: 6128596
    [Abstract] [Full Text] [Related]

  • 39. The effectiveness of ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled study.
    van de Wal HJ, Wijn PF, van Lier HJ, Skotnicki SH.
    Int Angiol; 1987 Dec 11; 6(3):313-22. PubMed ID: 3329207
    [Abstract] [Full Text] [Related]

  • 40. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
    Baadsgaard O, Schmidt JF, Ironmann L.
    Ugeskr Laeger; 1983 Dec 05; 145(49):3814-6. PubMed ID: 6364517
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.